The global gene panel market size was valued at USD 2.5 billion in 2022 and is poised to grow at a CAGR of 19.5% during the forecast period 2023-2029. The primary factors that drive the gene panel market growth are the rising prevalence of chronic diseases, increasing industry initiatives, growing adoption of gene panel as it offers a lot of benefits, and technological advancements in diagnostic methods and services.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/gene-panel-market/

The global gene panel market Segmentation:

1) By Product Type: Alkali Halides, Oxide Compounds, and Rare Earth Metals.

2) Material Type: Sodium Iodide, Cesium Iodide, Lutetium Oxyorthosilicate & Lutetium–Yttrium Oxyorthosilicate, and Others.

3) Application: Medical Imaging, Nuclear Medicine, Radioprotection, Oil Exploration, Process Industry, Life Sciences, and Others.

4) End Users: Healthcare, Homeland Security & Defense, Nuclear Power Plants, Industrial Applications.

Hybridization-Based Approach to Dominate the Gene Panel Market:
Based on technique type, the hybridization-based approach holds the highest gene panel market share. Sequencing by hybridization method had been widely adopted in the last decades since its detection, to improve its precision. The method is pretty sensitive to the hybridization errors in the spectrum. Therefore, many methods intend to generate approaches that expand the resistance of the hybridization phase to errors. One of the improvements presented extra information to the spectrum, i.e., the projected location for each of its elements in the target sequence. Thus, a hybridization-based approach can boost the gene panel market growth.

North America Gene panel Market
North America holds the maximum global gene panel market share due to the increasing prevalence of chronic diseases such as cancer, and technological advancements in gene panel products. North America leads the global market due to entrenched research infrastructure, increasing funding from public and private sectors, and rising collaborations among global key players have contributed to increasing the sales of gene panels in this region. Apart from this, the major factor that drives the market in this region are patients’ need for effective and safe treatment and the increasing demand for personalized medicines. According to NIH, 1,806,509 people were diagnosed with cancer in the United States and 606,520 cases of death were reported.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players

The global gene panel market further reveals that the key players are implementing strategies such as the extension of product collection through research and development activities, product launches, acquisitions, mergers, and strategic alliances to improve their market position and strengthen the market revenue share. In February 2022, Invitae announced the presence of LiquidPlex Dx™ and FusionPlex Dx® in Europe which offers high-quality inventions for accurate oncology to combat cancer.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=59026      

Key players’ profiles in the gene panel market report are Illumina, Inc, Thermo Fisher Scientific, Agilent Technologies, Qiagen, BGI, Eurofins Scientific, F. Hoffmann-La Roche Ag, Integrated DNA Technologies, GATC Biotech Ag, Genewiz, Inc., Novogene Corporation, Personali, Archerdx, Genedx, Centogene Ag, Oxford Gene Technology, Primbio Research Institute, Fulgent Genetics, Gene Dx, Blueprint Genetics, Invitae Corporation.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and produce high-quality research reports. We have over five hundred clients with a good business partnership the capacity to provide in-depth research analysis for more than thirty countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and our services.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747